The FTC’s ability to challenge Amazon’s acquisition remains uncertain, with Commission Chair Lina Khan known to be skeptical of Big Tech. Amazon has even asked for her recusal from antitrust cases. While there is no guarantee that the FTC will succeed in blocking the acquisition, One Medical’s focus on healthcare raises unique privacy concerns that are not always present in tech acquisitions. Furthermore, One Medical is considerably larger than Within, whose acquisition by Meta the FTC recently failed to block.
